Transplant Infectious Disease最新文献

筛选
英文 中文
EBV-Related Posttransplant Lymphoproliferative Disorder After Transplantation of EBV-Infected Peripheral Blood Stem Cell Collection With Posttransplant Cyclophosphamide as GVHD Prophylaxis. 移植后环磷酰胺预防ebv感染外周血干细胞移植后与ebv相关的淋巴增生性疾病
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-28 DOI: 10.1111/tid.70287
Raymond Ruibo Zhang, Ashvind Prabahran, Andrew Grigg
{"title":"EBV-Related Posttransplant Lymphoproliferative Disorder After Transplantation of EBV-Infected Peripheral Blood Stem Cell Collection With Posttransplant Cyclophosphamide as GVHD Prophylaxis.","authors":"Raymond Ruibo Zhang, Ashvind Prabahran, Andrew Grigg","doi":"10.1111/tid.70287","DOIUrl":"https://doi.org/10.1111/tid.70287","url":null,"abstract":"","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70287"},"PeriodicalIF":2.5,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148607847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Significance of Organ Preservation Fluid Cultures in Pediatric Abdominal Solid Organ Transplantation. 器官保存液培养在小儿腹部实体器官移植中的临床意义。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-21 DOI: 10.1111/tid.70282
Hassan A Jamal, Yong K Kwon, Pamela L Valentino, Jodi M Smith, Patrick J Healey, Zheyi Teoh
{"title":"Clinical Significance of Organ Preservation Fluid Cultures in Pediatric Abdominal Solid Organ Transplantation.","authors":"Hassan A Jamal, Yong K Kwon, Pamela L Valentino, Jodi M Smith, Patrick J Healey, Zheyi Teoh","doi":"10.1111/tid.70282","DOIUrl":"https://doi.org/10.1111/tid.70282","url":null,"abstract":"<p><strong>Background: </strong>Pediatric data on preservation fluid cultures (PFCs) and their ability to predict preservation fluid-related posttransplant infections (PF-I) remain uncertain. In addition, clinical guidelines do not provide uniform recommendations regarding when to obtain PFC or how to manage positive results, particularly for children. In this study, we aimed to evaluate PFC-positive status and PF-I in pediatric abdominal solid organ transplant (aSOT) recipients.</p><p><strong>Methods: </strong>We conducted a retrospective, single pediatric center study of aSOT-recipients between 2012 and 2024, where PFCs were obtained routinely. Data were collected via chart review and included prespecified outcomes such as posttransplant bacterial infections, allograft rejection, unexpected return to the operating room, prolonged hospitalization, and death within 30 days posttransplant. PF-I was defined as a culture-concordant infection in the setting of PFC-positive status.</p><p><strong>Results: </strong>Among 337 aSOT recipients, PFCs were positive in 49 patients (14.5%). Coagulase-negative Staphylococci and Cutibacterium spp. were the most isolated organisms (63%). Infectious complications were more frequent in patients with PFC-positive status (30.6% vs. 18.4%; p = 0.049). Two PF-I episodes (4.1% of PFC-positive status) were identified, both in infant liver transplant recipients, involving vancomycin-resistant Enterococcous and methicillin-sensitive Staphylococcus aureus. At 30 days after transplantation, a higher percentage of the PFC-positive group remained hospitalized (18.4% vs. 8.7%; p = 0.037), whereas of the proportion of rejection, reoperation, and mortality was similar.</p><p><strong>Conclusions: </strong>PFC-positive status and PF-I were uncommon in this cohort. The utility of routine bacterial PFC is primarily to identify the growth of organisms considered pathogenic and to guide preemptive antibiotic therapy.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70282"},"PeriodicalIF":2.5,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real World Utilization of Protocolized T-Cell Immunity Panel Screening in Cytomegalovirus Seropositive Kidney Transplant Recipients. t细胞免疫筛选在巨细胞病毒血清阳性肾移植受者中的实际应用
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-21 DOI: 10.1111/tid.70283
Hanna Kleiboeker, Cassilyn Streblow, Jillian Descourouez, Christopher Saddler, John Rice, Didier Mandelbrot, Jon Odorico, Margaret Jorgenson
{"title":"Real World Utilization of Protocolized T-Cell Immunity Panel Screening in Cytomegalovirus Seropositive Kidney Transplant Recipients.","authors":"Hanna Kleiboeker, Cassilyn Streblow, Jillian Descourouez, Christopher Saddler, John Rice, Didier Mandelbrot, Jon Odorico, Margaret Jorgenson","doi":"10.1111/tid.70283","DOIUrl":"https://doi.org/10.1111/tid.70283","url":null,"abstract":"<p><strong>Background: </strong>Recently updated guidelines suggest monthly cytomegalovirus (CMV) cell-mediated immunity (CMI) testing in seropositive (R+) kidney transplant recipients to stratify posttransplant CMV risk and guide prophylaxis. UW Health has protocolized T-cell immunity panel (TCIP) testing since 2023. The purpose was to assess real-world implementation of TCIP testing and the feasibility of this approach.</p><p><strong>Methods: </strong>This retrospective cohort study included adult R+ renal transplant (RTX) recipients transplanted March 1, 2023, to April 9, 2025, received lymphocyte depleting induction and completed TCIP testing at 3 months posttransplant.</p><p><strong>Results: </strong>Here, 234 patients were eligible for protocolized TCIP testing during the study period, with 160 patients obtaining a TCIP (68.4%). Mean time to TCIP draw was 94 ± 15.6 days post-RTX. Of those who obtained TCIP, 75 had positive, 57 negative, and 28 with indeterminate results. Significantly more patients with indeterminate TCIP received alemtuzumab induction (8.0% vs. 8.8%vs. 89.3%, p < 0.0001). Positive TCIP facilitated significantly shorter prophylaxis duration (153.8 vs. 172.2 vs. 180.1 days, p = 0.003). WBC were significantly lower among patients with an indeterminate TCIP (6.3 vs. 6.1 vs. 4.4 × 10<sup>3</sup> cells/mm<sup>3</sup>, p = 0.0006). Patients with indeterminate TCIP were more likely to have ALC ≤ 400 cells/µL (32.0% vs. 33.3% vs. 89.3%, p < 0.0001). Incidence of post-prophylaxis CMV infection was comparable.</p><p><strong>Conclusion: </strong>In this study, implementing protocolized TCIP testing at 3 months posttransplant in R+ kidney transplant recipients was feasible, with the main limitation being lab related draw-time considerations. Based on our center specific experience, stratification based on patient-specific factors should be considered before widespread implementation to optimize evaluable results given cost burden associated with testing.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70283"},"PeriodicalIF":2.5,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible Donor-Derived Tuberculosis in an Orthotopic Heart Transplant Recipient. 原位心脏移植受者可能的供体来源结核。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-05-21 DOI: 10.1111/tid.70243
Phani V Akella, Rachel Sigler
{"title":"Possible Donor-Derived Tuberculosis in an Orthotopic Heart Transplant Recipient.","authors":"Phani V Akella, Rachel Sigler","doi":"10.1111/tid.70243","DOIUrl":"10.1111/tid.70243","url":null,"abstract":"","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70243"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147983486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty Status Predicts Urinary Tract Infection Risk Following Kidney Transplant. 虚弱状态预测肾移植后尿路感染风险。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-03-15 DOI: 10.1111/tid.70204
Rebecca Unterborn, Liza M Creel, Kristine M Erlandson, Maheen Z Abidi
{"title":"Frailty Status Predicts Urinary Tract Infection Risk Following Kidney Transplant.","authors":"Rebecca Unterborn, Liza M Creel, Kristine M Erlandson, Maheen Z Abidi","doi":"10.1111/tid.70204","DOIUrl":"10.1111/tid.70204","url":null,"abstract":"<p><strong>Introduction: </strong>Urinary tract infections (UTIs) are the most common infectious complication in kidney transplant (KT) recipients. UTI risk is associated with frailty in older adults, and UTIs may exacerbate frailty. However, this relationship has not been described in KT recipients who are at both greater risk of frailty and UTIs.</p><p><strong>Methods: </strong>We conducted a retrospective chart review of 90 KT recipients aged ≥ 50 years who underwent KT between January and July 2021 and had ≥ 12 months of post-transplant follow-up. UTIs were identified at the time of each occurrence. Frailty was assessed at baseline using the modified Rockwood-20 frailty index (mFI); scores ≥ 0.25 were considered frail, 0.08-0.24 pre-frail, and < 0.08 non-frail. The primary outcome was cumulative UTI occurrence based on frailty status, analyzed using Cox proportional hazards regression.</p><p><strong>Results: </strong>Among 90 KT recipients, 33 (37%) developed ≥ 1 UTI. Notably, 45% of KT recipients with UTIs were frail, compared to 25% of KT recipients without UTIs. Compared to non-frail KT recipients, frail KT recipients had a significantly higher risk of UTIs (HR 8.13, 95% CI 1.89, 34.91; p = 0.005), as did pre-frail KT recipients (HR 4.51, 95% CI 1.02, 19.92; p = 0.047). Frail KT recipients also experienced earlier UTI onset, with 12 out of 21 total UTIs (57%) occurring within the first 30 days post-KT.</p><p><strong>Conclusion: </strong>Frailty and prefrailty are associated with increased UTI risk in KT recipients. These findings highlight the importance of frailty assessment in post-transplant care and suggest the need for targeted interventions to reduce UTI risk in this vulnerable population.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70204"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13253013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147463767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparing for the Next Pandemic: Novel Insights, Prevention and Treatment of Emerging and Established Respiratory Viruses. 为下一次大流行做准备:新出现的和已建立的呼吸道病毒的新见解、预防和治疗。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-07-10 DOI: 10.1111/tid.70274
Victoria G Hall, Gemma K Reynolds, Joanna M Schaenman
{"title":"Preparing for the Next Pandemic: Novel Insights, Prevention and Treatment of Emerging and Established Respiratory Viruses.","authors":"Victoria G Hall, Gemma K Reynolds, Joanna M Schaenman","doi":"10.1111/tid.70274","DOIUrl":"10.1111/tid.70274","url":null,"abstract":"","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70274"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148424429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infectious Risk Donor Status in Uncontrolled Donation After Circulatory Death and Liver Transplantation. 循环性死亡和肝移植后非受控捐献的感染风险供者状况。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-05-22 DOI: 10.1111/tid.70248
Chiara Lazzeri, Paolo Antonio Grossi, Manuela Bonizzoli, Davide Ghinolfi, Arianna Trizzino, Giuseppe Feltrin, Adriano Peris
{"title":"Infectious Risk Donor Status in Uncontrolled Donation After Circulatory Death and Liver Transplantation.","authors":"Chiara Lazzeri, Paolo Antonio Grossi, Manuela Bonizzoli, Davide Ghinolfi, Arianna Trizzino, Giuseppe Feltrin, Adriano Peris","doi":"10.1111/tid.70248","DOIUrl":"10.1111/tid.70248","url":null,"abstract":"<p><strong>Backgrounds: </strong>Few data are so far available concerning the infectious risk donor profile in uncontrolled donation after circulatory death (uDCDs), despite the high incidence of infectious complications observed in out-of-hospital cardiac arrest patients.</p><p><strong>Methods: </strong>We assessed the donor risk profile in utilized uDCD donors consecutively assessed from 2018 to 2024, focusing on the outcome of liver transplant recipients.</p><p><strong>Results: </strong>Fifty-two consecutive utilized uDCDs were included. In 16 uDCDs, blood cultures were positive. In all these cases, Gram-positive bacteria were observed, mainly cocci (14/16, 88%). These microorganisms were considered contaminants. None of these microorganisms were isolated in recipients. No donor-related infection was detected in the 24 liver transplant recipients.</p><p><strong>Conclusions: </strong>According to our results, uDCDs show a low risk of infection transmission to the recipients. Nevertheless, a careful and systematic approach to donor evaluation should be pursued and implemented, considering the restricted time frame for assessment and the urgent procedures performed, considering the characteristics of uDCD (comprising the performance of an urgent procedure). Transplant coordinators should promptly report culture positivity in one of the collected samples, thus allowing the timely initiation of antibiotic therapy in the recipients. In uDCD donors, some information on infectious risk may be lacking, considering the limited time and that a urine culture may not be feasible since these donors may be anuric.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70248"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147989211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and Outcomes of Extrapulmonary Invasive Fungal Infections After Kidney Transplantation in Northern India. 印度北部肾移植术后肺外侵袭性真菌感染的流行病学和结局。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-05-14 DOI: 10.1111/tid.70218
Abdullah, Anupma Kaul, Rungmei Marak, Manas Behera, Narayan Prasad, Manas Patel, Dharmendra Bhaduaria, Ravi Kushwaha, Monika Yachha, Akash Mishra
{"title":"Epidemiology and Outcomes of Extrapulmonary Invasive Fungal Infections After Kidney Transplantation in Northern India.","authors":"Abdullah, Anupma Kaul, Rungmei Marak, Manas Behera, Narayan Prasad, Manas Patel, Dharmendra Bhaduaria, Ravi Kushwaha, Monika Yachha, Akash Mishra","doi":"10.1111/tid.70218","DOIUrl":"10.1111/tid.70218","url":null,"abstract":"<p><strong>Background: </strong>Extrapulmonary invasive fungal infections (IFIs) in kidney transplant recipients (KTRs) are understudied, particularly in endemic, resource-limited settings. This study evaluated the epidemiology, risk factors, and outcomes of extrapulmonary IFIs in KTRs in northern India.</p><p><strong>Methods: </strong>In this nested case-control study of 1649 KTRs (2007-2022), microbiologically proven extrapulmonary IFI cases were identified from microbiology and histopathology databases.</p><p><strong>Results: </strong>Extrapulmonary IFI occurred in 67 KTRs (4.1%). Cryptococcosis (46.3%) and candidiasis (20.9%) were the predominant infections. The central nervous system was the most common site (44.8%), followed by the bloodstream (22.4%). The mean age was 46.78 years, and 85.1% were males. The median time to infection was 55 months posttransplant, and 79.1% of infections occurred beyond 1 year posttransplant. Median estimated glomerular filtration rate (eGFR) was 43 mL/min/1.73 m<sup>2</sup>, and acute graft dysfunction was present in 49.3% cases. Comorbidities included diabetes (44.8%), chronic renal allograft injury (59.7%), acute rejection (38.8%), bacterial infection (26.9%), and cytomegalovirus disease (13.4%). Diabetes (OR 2.27, p = 0.038) and methylprednisolone pulses for rejection (OR 3.19, p = 0.025) were independently associated with IFI. Infection-related mortality was 35.8%; disseminated infection (HR 3.72, p = 0.020) and requirement for kidney replacement therapy (KRT) (HR 3.98, p = 0.011) independently predicted death. Note that, 5- and 10-year patient survival was significantly lower in cases than in controls (74.1% and 48.3% vs. 92.3% and 74.9%; p = 0.008), whereas death-censored graft survival was comparable.</p><p><strong>Conclusions: </strong>Extrapulmonary IFIs are late-onset and commonly present as cryptococcal meningitis or candidemia. Diabetes and methylprednisolone pulses increase infection risk, while dissemination and KRT requirement predict mortality.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70218"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147942723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate Donor-Derived Hepatitis C Transmission Following Kidney Transplantation: A Two-Case Observation. 肾移植后立即供体来源的丙型肝炎传播:两例观察。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-05-05 DOI: 10.1111/tid.70225
I-Ru Chen, Wen-Pang Su, Ping-Chin Lai
{"title":"Immediate Donor-Derived Hepatitis C Transmission Following Kidney Transplantation: A Two-Case Observation.","authors":"I-Ru Chen, Wen-Pang Su, Ping-Chin Lai","doi":"10.1111/tid.70225","DOIUrl":"10.1111/tid.70225","url":null,"abstract":"","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70225"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidrug-Resistant Gram-Negative Urinary Tract Infections (UTIs) Increase the Risk of Rejection, CMV Viremia, and Graft Loss After Kidney Transplantation. 多药耐药革兰氏阴性尿路感染(uti)增加肾移植后排斥反应、巨细胞病毒血症和移植物丢失的风险。
IF 2.5 4区 医学
Transplant Infectious Disease Pub Date : 2026-07-01 Epub Date: 2026-04-02 DOI: 10.1111/tid.70212
Alessandra Palmisano, Marta D'Angelo, Federica Brillo, Daniel Salvetti, Alice Parmigiani, Alessio Di Maria, Francesco Saracino, Eleonora Salsi, Micaela Gentile, Giuseppe Daniele Benigno, Ilaria Gandolfini, Enrico Fiaccadori, Paolo Cravedi, Umberto Maggiore
{"title":"Multidrug-Resistant Gram-Negative Urinary Tract Infections (UTIs) Increase the Risk of Rejection, CMV Viremia, and Graft Loss After Kidney Transplantation.","authors":"Alessandra Palmisano, Marta D'Angelo, Federica Brillo, Daniel Salvetti, Alice Parmigiani, Alessio Di Maria, Francesco Saracino, Eleonora Salsi, Micaela Gentile, Giuseppe Daniele Benigno, Ilaria Gandolfini, Enrico Fiaccadori, Paolo Cravedi, Umberto Maggiore","doi":"10.1111/tid.70212","DOIUrl":"10.1111/tid.70212","url":null,"abstract":"<p><strong>Background: </strong>Multidrug-resistant (MDR) Gram-negative UTIs caused by extended-spectrum β-lactamases (ESBL) and carbapenem-resistant Enterobacteriaceae (CRE) are increasingly common in kidney transplant recipients (KTR), yet their clinical consequences relative to other Gram-negative infections remain unclear.</p><p><strong>Methods: </strong>In this single-center study from a high-endemic area, we retrospectively evaluated the impact of MDR colonization (Colonization), MDR Gram-negative infection (MDR Infection), presumptive MDR infection (i.e., no isolates available; Presump. MDR), and non-MDR Gram-negative infection (non-MDR Inf.) on major post-transplant complications, including CMV and BKPyV viremia, acute rejection, donor-specific antibodies (DSA), graft function, and overall transplant failure. We used multivariable cause-specific hazard Cox regression models with time-varying covariates and random-coefficient mixed models.</p><p><strong>Results: </strong>Among 521 KTRs, distributed across overlapping conditions, 212 (40.7%) had MDR Colonization, 92 (17.7%) MDR Infection, 61 (11.7%) Presump. MDR, 67 (12.9%) non-MDR Inf., and 242 (46.4%) had no infection. Compared with No Infection group, only MDR infection was associated with a steeper decline in eGFR slope (<sub>-5.50</sub>-2.91<sub>-0.33</sub> mL/min/1.73 m<sup>2</sup> per year; p = 0.027) and increased incidence of transplant failure (adjusted hazard, aHR, associated with history of MDR Infection = <sub>1.76</sub> 4.11<sub>9.61</sub>; p = 0.001. MDR infection history was also the only condition associated with CMV viremia (aHR = <sub>1.05</sub>1.83<sub>3.18</sub>; p = 0.034), and with rejection (aHR = <sub>1.03</sub>1.69<sub>2.76</sub>; p = 0.036), though it was not associated with BKPyV viremia or de novo DSA. Colonization, Presump. Inf., and non-MDR Inf. were not independently associated with complications or transplant failure.</p><p><strong>Conclusion: </strong>Documented MDR Gram-negative UTIs, but not colonization or non-MDR UTI, are independently associated with acute rejection, CMV viremia, and poorer kidney allograft outcomes.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70212"},"PeriodicalIF":2.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13450159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147595017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书